Anti-USP28 antibody [EPR4249(2)]
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(14 Publications)
Rabbit Recombinant Monoclonal USP28 antibody. Suitable for WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 14 publications.
View Alternative Names
KIAA1515, USP28, Ubiquitin carboxyl-terminal hydrolase 28, Deubiquitinating enzyme 28, Ubiquitin thioesterase 28, Ubiquitin-specific-processing protease 28
- Flow Cyt (Intra)
Lab
Flow Cytometry (Intracellular) - Anti-USP28 antibody [EPR4249(2)] (AB126604)
Intracellular Flow Cytometry analysis of HeLa (human cervix adenocarcinoma) cells labeling USP28 with unpurified ab126604 at 1/200 dilution (1ug/ml) (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. A Goat anti rabbit IgG (Alexa Fluor® 488) (ab150077) (1/2000 dilution) was used as the secondary antibody. Rabbit monoclonal IgG (Black) (ab172730) was used as the isotype control, Cell without incubation with primary antibody and secondary antibody (Blue) were used as the unlabeled control.
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-USP28 antibody [EPR4249(2)] (AB126604)
ab126604 at 1/50 dilution staining USP28 in HeLa cells by Immunofluorescence.
- WB
Lab
Western blot - Anti-USP28 antibody [EPR4249(2)] (AB126604)
Western blot : Anti-USP28 antibody [EPR4249(2)] ab126604 staining at 1/1000 dilution, shown in green; Mouse anti-CANX ab238078 loading control staining at 1/20000 dilution, shown in magenta. A band was observed at 122 kDa in Wild-type A549 Nuclear cell lysates with no signal observed at this size in USP28 knockout A549 Nuclear cell line. To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3% Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit 800CW and Goat anti-Mouse 680RD at 1/20,000 dilution.
All lanes:
Western blot - Anti-USP28 antibody [EPR4249(2)] (ab126604) at 1/1000 dilution
Lane 1:
Wild-type A549 Nuclear cell lysates at 20 µg
Lane 2:
USP28 knockout A549 Nuclear cell lysates at 20 µg
Lane 3:
HeLa cell lysates at 20 µg
Secondary
All lanes:
Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution
Predicted band size: 122 kDa
Observed band size: 122 kDa
false
- WB
Unknown
Western blot - Anti-USP28 antibody [EPR4249(2)] (AB126604)
All lanes:
Western blot - Anti-USP28 antibody [EPR4249(2)] (ab126604) at 1/1000 dilution
Lane 1:
293T cell lysate at 10 µg
Lane 2:
HeLa cell lysate at 10 µg
Lane 3:
HT1376 cell lysate at 10 µg
Lane 4:
Human heart tissue lysate at 10 µg
Lane 5:
SW480 cell lysate at 10 µg
Lane 6:
A431 cell lysate at 10 µg
Secondary
All lanes:
Goat anti-Rabbit HRP at 1/2000 dilution
Predicted band size: 122 kDa
false
- OI-RD Scanning
Unknown
OI-RD Scanning - Anti-USP28 antibody [EPR4249(2)] (AB126604)
We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.
Related conjugates and formulations (7)
-
Anti-USP28 antibody [EPR4249(2)] - BSA and Azide free
-
660 APC
APC Anti-USP28 antibody [EPR4249(2)]
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-USP28 antibody [EPR4249(2)]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-USP28 antibody [EPR4249(2)]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-USP28 antibody [EPR4249(2)]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-USP28 antibody [EPR4249(2)]
-
578 PE
PE Anti-USP28 antibody [EPR4249(2)]
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purity
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This deubiquitinase regulates several cellular processes such as DNA damage response cell cycle progression and apoptosis. USP28 influences protein stability by directly associating with components of the c-MYC signaling pathway. It is known to interact with and stabilize Fbw7 which is part of the ubiquitin ligase complex thereby affecting the turnover of proteins like c-MYC and cyclin E. Through these interactions USP28 helps maintain normal levels of these important regulators for healthy cellular functions.
Pathways
The enzyme plays an important part in the DNA damage response and MAPK signaling pathways. These pathways ensure proper genomic integrity and cell proliferation. USP28 enhances the stability of the key regulatory protein c-MYC in the p53 pathway emphasizing its role in cell cycle regulation. Its interaction with other proteins like Fbw7 and c-MYC allows it to modulate the rate of cell growth and division indicating its importance in controlled cellular pathways.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (14)
Recent publications for all applications. Explore the full list and refine your search
Theranostics 15:9819-9837 PubMed41041071
2025
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 15:11054 PubMed40169639
2025
Applications
Unspecified application
Species
Unspecified reactive species
Science (New York, N.Y.) 383:1441-1448 PubMed38547292
2024
Applications
Unspecified application
Species
Unspecified reactive species
Developmental cell 58:2495-2509.e6 PubMed37683630
2023
Applications
Unspecified application
Species
Unspecified reactive species
British journal of cancer 128:1005-1018 PubMed36635500
2023
Applications
Unspecified application
Species
Unspecified reactive species
The EMBO journal 41:e109187 PubMed35191554
2022
Applications
Unspecified application
Species
Unspecified reactive species
eLife 10: PubMed34636321
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 12:887 PubMed34584067
2021
Applications
Unspecified application
Species
Unspecified reactive species
Cell chemical biology 28:1758-1771.e13 PubMed34129829
2021
Applications
Unspecified application
Species
Unspecified reactive species
Molecular cell 81:2596-2610.e7 PubMed33961796
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com